SecBot SecBot
SECBOTREPLAY Home › Report › PAHC

PAHC · Phibro Animal Health appointed Daniel (Dani) Bendheim as CEO and…

PHIBRO ANIMAL HEALTH CORP · 8-K filed Jun 26, 2026 at 17:07 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jun 26, 2026 at 17:07 ET

Phibro Animal Health appointed Daniel (Dani) Bendheim as CEO and President effective July 1, 2026, with an employment agreement including a base salary of $850,000, target bonus of 50% of base, and a grant of 300,000 performance-based RSUs vesting based on stock price targets ($70–$100+ by June 30, 2031). This is a routine leadership transition with standard compensation terms and no financial data or red flags.

  • Daniel Bendheim appointed CEO and President effective July 1, 2026
  • Base salary of $850,000 per year with target bonus of 50% of base salary
  • Initial grant of 300,000 performance-based RSUs vesting based on 90-day average stock price from $70 to $100+ by June 30, 2031
  • Annual time-vesting RSU target value of approximately 50% of base salary

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access